The American company plans to begin chip testing on six patients at a New York hospital.
An American startup called Synchron has already received approval from the relevant US authorities to conduct clinical trials of a neurochip that will link the brain and computer, reports Bloomberg.
Synchron has previously tested the device on four volunteers in Australia. The trial will now be conducted on six patients at a New York hospital.
The main task of the innovative device, which will be implanted into the human brain, is to help paralyzed people who will be able to control various gadgets using the power of thought.
Using a thin wire, the chip implanted in the brain will be connected to the implant located in the chest. It is important to note that the device will be connected to the body without surgery, that is, with penetration through the blood vessels at the base of the neck. All procedures will take about two hours.
Interestingly, according to the publication, this project is funded by the United States Department of Defense, which may indicate the department’s far-reaching plans for this development.
By the way, Synchron received permission to test the new technology earlier than the well-known company Elon Musk Neuralink, which had previously introduced the chip into the brain of a primate.
Work in this direction has been going on in the world for a long time, and scientists are interested in creating a device without any interference in the human body. This is probably why Neuralink technologies are not so promising and do not find support from stakeholders.
